Particle Sciences expands cGMP capabilities
With the addition of thin films
Particle Sciences, a US drug delivery contract research organisation (CRO), has added coating capabilities for preparing polymer film-based drug products from liquid formulations.
The firm, based in Bethlehem, PA, has added the semi-automated coating equipment to meet increasing demand for thin film-based products.
Garry Gwozdz, director of Formulation Services, said: ‘Increasingly, we are seeing a demand for thin film-based products, particularly with respect to transdermal drug-eluting patch products, and rapidly dissolving strips.
‘The acquisition of semi-automated coating equipment will allow us to screen more formulation approaches, and get our clients into the clinic faster with a commercially representative film-based product.’
Particle Sciences already had a cGMP hot-melt film extrusion capability and with the addition of coating and drying capabilities for liquid-based formulations, its clients will have access to a complete array of viable and scalable film-manufacturing technologies.
The CRO focuses on BCS II/III/IV molecules, biologics and highly potent compounds through a variety of technologies including emulsions, gels, micro and nano-particulates, drug/device combination products, solid solutions and others.
